For Immediate Release: June 9, 2017
Contact: Mr Benito Novas
info@stemcellsgroup.com
Phone + 305 560 5337
GLOBAL STEM CELLS GROUP TO LAUNCH FDA-REGISTERED SVF KITS AT THIS YEAR’S FIME EVENT
Orlando, FL – Global Stem Cells Group, an international network of stem cell medicine students, academics, practitioners, and researchers all passionate about sharing their findings and advancements with regards to the potential of regenerative medicine, this week announced they will be launching their FDA-Registered SVF kits at this year’s Florida International Medical Expo (FIME).
With the event now in its 27th year, FIME is the largest medical trade fair across the Americas. As such, Global Stem Cells Group felt it is the perfect place to launch their SVF Kit, which is both FDA-Register and CE-certified. Also known as the STEMPIA Kit, these kits are being used in clinical procedures like intra-articular injections, cosmetic surgery, acne scarring, dermal injections, stem cell enriched fat transfers, chronic ulcers, and other conditions today.
“These one-of-a-kind kits are built with N-Biotek technology that has been proven and verified in multiple patient outcomes,” said Mr. Benito Novas, Founder and Owner of Global Stem Cells Group. “With FIME being such a remarkable international gathering among medical personnel, we are excited to be introducing these kits to all event attendees.”
The SVF Kits are sterilized ADSC isolation close systems with proprietary technology that guarantees the highest yield and viability for minimizing contamination.
To be introduced at FIME, the three-day event will host an exhibition of over 22,000 medical and healthcare trade professionals from North, Central, and South America. Additionally, there will be 1,500+ national and international companies showcasing new and refurbished medical and hospital equipment, technology, products, and supplies – Global Stem Cells Group being one of them.
“Spread the word on the availability of our new kits at this year’s FIME event, kicking off August 8, 2017,” said Mr. Novas.
